Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 18, 2017
[ Mon, Sep 18th 2017
] - WOPRAI
Fri, September 15, 2017
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
Kennen MacKay Initiated (AGIO) at Buy and Held Target at $78 on, Sep 15th, 2017
Kennen MacKay of RBC Capital, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Buy and Held Target at $78 on, Sep 15th, 2017.
Kennen has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Debjit Chattopadhyay of "Janney Montgomery Scott" Downgraded from Strong Buy to Hold on, Monday, June 26th, 2017
This is the rating of the analyst that currently disagrees with Kennen
- Michael Schmidt of "Leerink Swann" Upgraded from Hold to Buy on, Wednesday, August 2nd, 2017
